这是一篇来自已证抗体库的有关人类 IKKbeta的综述,是根据86篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合IKKbeta 抗体。
IKKbeta 同义词: IKK-beta; IKK2; IKKB; IMD15; IMD15A; IMD15B; NFKBIKB

艾博抗(上海)贸易有限公司
domestic rabbit 单克隆(Y466)
  • 免疫印迹; 小鼠; 1:1000; 图 4g
艾博抗(上海)贸易有限公司 IKKbeta抗体(Abcam, ab32135)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 4g). Int J Mol Med (2021) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 1:500; 图 3b
艾博抗(上海)贸易有限公司 IKKbeta抗体(Abcam, ab194528)被用于被用于免疫印迹在人类样本上浓度为1:500 (图 3b). Oncogene (2021) ncbi
domestic rabbit 单克隆(EPR6043)
  • 免疫印迹; 大鼠; 1:1000; 图 5a
艾博抗(上海)贸易有限公司 IKKbeta抗体(Abcam, ab124957)被用于被用于免疫印迹在大鼠样本上浓度为1:1000 (图 5a). Biosci Rep (2019) ncbi
domestic rabbit 单克隆(Y466)
  • 免疫印迹; 人类; 图 s3b
艾博抗(上海)贸易有限公司 IKKbeta抗体(Abcam, ab32135)被用于被用于免疫印迹在人类样本上 (图 s3b). Mol Cell (2019) ncbi
domestic rabbit 单克隆(Y466)
  • 免疫印迹; 小鼠; 图 6a
艾博抗(上海)贸易有限公司 IKKbeta抗体(Abcam, ab32135)被用于被用于免疫印迹在小鼠样本上 (图 6a). Cell Physiol Biochem (2017) ncbi
domestic rabbit 多克隆
  • 免疫细胞化学; 小鼠; 图 s3
艾博抗(上海)贸易有限公司 IKKbeta抗体(Abcam, Ab194528)被用于被用于免疫细胞化学在小鼠样本上 (图 s3). Nat Commun (2016) ncbi
domestic rabbit 单克隆(Y466)
  • 免疫印迹; 小鼠; 图 5
艾博抗(上海)贸易有限公司 IKKbeta抗体(abcam, ab32135)被用于被用于免疫印迹在小鼠样本上 (图 5). Am J Transl Res (2016) ncbi
domestic rabbit 单克隆(Y466)
  • 免疫印迹; 小鼠; 图 4a
艾博抗(上海)贸易有限公司 IKKbeta抗体(Abcam, ab32135)被用于被用于免疫印迹在小鼠样本上 (图 4a). elife (2016) ncbi
domestic rabbit 单克隆(Y466)
  • 免疫沉淀; 人类; 1:500; 图 2f
艾博抗(上海)贸易有限公司 IKKbeta抗体(Abcam, ab32135)被用于被用于免疫沉淀在人类样本上浓度为1:500 (图 2f). Sci Rep (2016) ncbi
domestic rabbit 单克隆(Y466)
  • 免疫印迹; 小鼠; 图 8
艾博抗(上海)贸易有限公司 IKKbeta抗体(Abcam, Y466)被用于被用于免疫印迹在小鼠样本上 (图 8). PLoS ONE (2015) ncbi
domestic rabbit 单克隆(Y466)
  • 免疫印迹; 大鼠; 图 5a
艾博抗(上海)贸易有限公司 IKKbeta抗体(Abcam, ab32135)被用于被用于免疫印迹在大鼠样本上 (图 5a). Sci Rep (2015) ncbi
圣克鲁斯生物技术
小鼠 单克隆(H-4)
  • 免疫印迹; 人类; 图 5h
圣克鲁斯生物技术 IKKbeta抗体(Santa Cruz, sc-8014)被用于被用于免疫印迹在人类样本上 (图 5h). J Biol Chem (2017) ncbi
小鼠 单克隆(H-4)
  • 免疫印迹; 人类; 1:1000; 图 5a
圣克鲁斯生物技术 IKKbeta抗体(Santa Cruz, sc8014)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 5a). Front Pharmacol (2016) ncbi
小鼠 单克隆(H-4)
  • 免疫印迹; 人类; 图 6
圣克鲁斯生物技术 IKKbeta抗体(Santa Cruz, sc-8014)被用于被用于免疫印迹在人类样本上 (图 6). Sci Rep (2015) ncbi
小鼠 单克隆(H-4)
  • 免疫印迹; 人类
圣克鲁斯生物技术 IKKbeta抗体(Santa Cruz Biotechnology, H4)被用于被用于免疫印迹在人类样本上. Nucleic Acids Res (2015) ncbi
小鼠 单克隆(H-4)
  • 免疫印迹; 人类; 图 3
圣克鲁斯生物技术 IKKbeta抗体(Santa Cruz, sc-8014)被用于被用于免疫印迹在人类样本上 (图 3). PLoS ONE (2015) ncbi
小鼠 单克隆(G-8)
  • 免疫组化-石蜡切片; 人类; 图 s2
  • 免疫印迹; 人类; 图 4
圣克鲁斯生物技术 IKKbeta抗体(Santa Cruz, sc-271782)被用于被用于免疫组化-石蜡切片在人类样本上 (图 s2) 和 被用于免疫印迹在人类样本上 (图 4). Oncotarget (2015) ncbi
赛默飞世尔
domestic rabbit 单克隆(J.10.3)
  • 免疫印迹; 人类
赛默飞世尔 IKKbeta抗体(Pierce Biotechnology, MA5-14857)被用于被用于免疫印迹在人类样本上. EMBO Mol Med (2013) ncbi
Novus Biologicals
小鼠 单克隆(10AG2)
  • 免疫细胞化学; 人类; 1:75; 图 s2a
Novus Biologicals IKKbeta抗体(Novus Biologicals, 10AG2)被用于被用于免疫细胞化学在人类样本上浓度为1:75 (图 s2a). Genes Dev (2016) ncbi
赛信通(上海)生物试剂有限公司
domestic rabbit 单克隆(D30C6)
  • 免疫印迹; 小鼠; 图 5c
赛信通(上海)生物试剂有限公司 IKKbeta抗体(Cell Signaling Technology, 8943S)被用于被用于免疫印迹在小鼠样本上 (图 5c). Clin Transl Med (2022) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 图 5i
赛信通(上海)生物试剂有限公司 IKKbeta抗体(cell signaling technology, cst2678)被用于被用于免疫印迹在小鼠样本上 (图 5i). Front Physiol (2021) ncbi
domestic rabbit 单克隆(D30C6)
  • 免疫印迹; 人类; 1:1000; 图 5a
赛信通(上海)生物试剂有限公司 IKKbeta抗体(Cell Signaling Technology, 8943)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 5a). Cancers (Basel) (2021) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 1:500; 图 s1c
赛信通(上海)生物试剂有限公司 IKKbeta抗体(Cell Signaling, 2684)被用于被用于免疫印迹在小鼠样本上浓度为1:500 (图 s1c). Environ Health Perspect (2021) ncbi
domestic rabbit 单克隆(D30C6)
  • 免疫印迹; 人类; 图 4g, 5h, s5a
赛信通(上海)生物试剂有限公司 IKKbeta抗体(Cell Signaling, 8943)被用于被用于免疫印迹在人类样本上 (图 4g, 5h, s5a). Protein Cell (2021) ncbi
domestic rabbit 单克隆(D30C6)
  • 免疫印迹; 小鼠; 图 6a
  • 免疫印迹; 人类; 图 1a, 7f
赛信通(上海)生物试剂有限公司 IKKbeta抗体(Cell Signaling Technology, 8943)被用于被用于免疫印迹在小鼠样本上 (图 6a) 和 被用于免疫印迹在人类样本上 (图 1a, 7f). Cell Death Dis (2021) ncbi
domestic rabbit 单克隆(C84E11)
  • 免疫印迹; pigs
赛信通(上海)生物试剂有限公司 IKKbeta抗体(Cell Signaling Technology, 2078)被用于被用于免疫印迹在pigs 样本上. Nucleic Acids Res (2021) ncbi
domestic rabbit 单克隆(D30C6)
  • 免疫印迹; 小鼠; 图 5h
赛信通(上海)生物试剂有限公司 IKKbeta抗体(CST, 8943)被用于被用于免疫印迹在小鼠样本上 (图 5h). J Nutr Biochem (2021) ncbi
domestic rabbit 单克隆(D30C6)
  • 免疫印迹; 小鼠; 图 3d
赛信通(上海)生物试剂有限公司 IKKbeta抗体(Cell Signaling Technology, 8943)被用于被用于免疫印迹在小鼠样本上 (图 3d). Int J Mol Sci (2021) ncbi
domestic rabbit 单克隆(D30C6)
  • 免疫印迹; 小鼠; 1:1000; 图 6e
赛信通(上海)生物试剂有限公司 IKKbeta抗体(Cell Signaling, 8943)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 6e). Cell Death Differ (2021) ncbi
domestic rabbit 单克隆(D30C6)
  • 免疫印迹; 小鼠; 图 3f, 6e
赛信通(上海)生物试剂有限公司 IKKbeta抗体(Cell Signaling, 8943)被用于被用于免疫印迹在小鼠样本上 (图 3f, 6e). Signal Transduct Target Ther (2021) ncbi
domestic rabbit 单克隆(C84E11)
  • 免疫印迹; 小鼠; 图 3f
赛信通(上海)生物试剂有限公司 IKKbeta抗体(Cell Signaling, 2078)被用于被用于免疫印迹在小鼠样本上 (图 3f). Signal Transduct Target Ther (2021) ncbi
domestic rabbit 单克隆(D30C6)
  • 免疫沉淀; 人类; 图 1c
  • 免疫印迹; 人类; 1:1000; 图 2c
赛信通(上海)生物试剂有限公司 IKKbeta抗体(CST, 8943)被用于被用于免疫沉淀在人类样本上 (图 1c) 和 被用于免疫印迹在人类样本上浓度为1:1000 (图 2c). Mol Cancer (2021) ncbi
domestic rabbit 单克隆(2C8)
  • 免疫印迹; 小鼠; 图 s4a
赛信通(上海)生物试剂有限公司 IKKbeta抗体(CST, 2370)被用于被用于免疫印迹在小鼠样本上 (图 s4a). Nat Commun (2020) ncbi
domestic rabbit 单克隆(C84E11)
  • 免疫印迹; 小鼠; 图 s4a
赛信通(上海)生物试剂有限公司 IKKbeta抗体(CST, 2078)被用于被用于免疫印迹在小鼠样本上 (图 s4a). Nat Commun (2020) ncbi
domestic rabbit 单克隆(C84E11)
  • 免疫组化; 小鼠; 1:100; 图 5b
  • 免疫印迹; 小鼠; 1:500; 图 5e
赛信通(上海)生物试剂有限公司 IKKbeta抗体(Cell Signaling Technology, 2078)被用于被用于免疫组化在小鼠样本上浓度为1:100 (图 5b) 和 被用于免疫印迹在小鼠样本上浓度为1:500 (图 5e). elife (2020) ncbi
domestic rabbit 单克隆(C84E11)
  • 免疫印迹; 小鼠; 1:1000; 图 5d
赛信通(上海)生物试剂有限公司 IKKbeta抗体(Cell Signaling Technology, 2078)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 5d). Cell Death Dis (2020) ncbi
domestic rabbit 单克隆(D30C6)
  • 免疫印迹; 小鼠; 1:1000; 图 5d
赛信通(上海)生物试剂有限公司 IKKbeta抗体(Cell Signaling Technology, 8943)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 5d). Cell Death Dis (2020) ncbi
domestic rabbit 单克隆(D30C6)
  • 免疫印迹; 小鼠; 1:1000; 图 4b, s12b
赛信通(上海)生物试剂有限公司 IKKbeta抗体(Cell Signaling, 8943)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 4b, s12b). Nat Commun (2020) ncbi
domestic rabbit 单克隆(D30C6)
  • 免疫印迹; 大鼠; 图 7a
  • 免疫印迹; 人类; 图 10a
赛信通(上海)生物试剂有限公司 IKKbeta抗体(Cell Signaling, 8943)被用于被用于免疫印迹在大鼠样本上 (图 7a) 和 被用于免疫印迹在人类样本上 (图 10a). Mol Ther Nucleic Acids (2020) ncbi
domestic rabbit 单克隆(D30C6)
  • 免疫印迹; 人类; 图 5c
赛信通(上海)生物试剂有限公司 IKKbeta抗体(Cell Signaling, 8943)被用于被用于免疫印迹在人类样本上 (图 5c). Mol Oncol (2020) ncbi
domestic rabbit 单克隆(D30C6)
  • 免疫印迹; 人类; 图 e3s
赛信通(上海)生物试剂有限公司 IKKbeta抗体(Cell Signaling, D30C6)被用于被用于免疫印迹在人类样本上 (图 e3s). Nature (2020) ncbi
domestic rabbit 单克隆(D30C6)
  • 免疫印迹; 大鼠; 图 6i
赛信通(上海)生物试剂有限公司 IKKbeta抗体(Cell Signaling, 8943)被用于被用于免疫印迹在大鼠样本上 (图 6i). Aging (Albany NY) (2019) ncbi
domestic rabbit 单克隆(2C8)
  • 免疫印迹基因敲除验证; 人类; 图 4g
赛信通(上海)生物试剂有限公司 IKKbeta抗体(Cell Signaling Technology, 2370)被用于被用于免疫印迹基因敲除验证在人类样本上 (图 4g). Mol Cell Biol (2020) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 4a
赛信通(上海)生物试剂有限公司 IKKbeta抗体(Cell Signaling Technology, 2678)被用于被用于免疫印迹在人类样本上 (图 4a). PLoS Pathog (2019) ncbi
domestic rabbit 单克隆(D30C6)
  • 免疫印迹; 小鼠; 1:1000; 图 5a
赛信通(上海)生物试剂有限公司 IKKbeta抗体(Cell Signaling, 8943s)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 5a). CNS Neurosci Ther (2020) ncbi
domestic rabbit 单克隆(C84E11)
  • 免疫印迹; 人类; 图 s4a
赛信通(上海)生物试剂有限公司 IKKbeta抗体(Cell Signaling, 2078S)被用于被用于免疫印迹在人类样本上 (图 s4a). J Immunol (2019) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 图 s1c
赛信通(上海)生物试剂有限公司 IKKbeta抗体(Cell Signaling, 2684P)被用于被用于免疫印迹在小鼠样本上 (图 s1c). Sci Adv (2019) ncbi
domestic rabbit 单克隆(D30C6)
  • 免疫印迹; 小鼠; 图 4b
赛信通(上海)生物试剂有限公司 IKKbeta抗体(Cell Signaling Technology, 8943)被用于被用于免疫印迹在小鼠样本上 (图 4b). Hepatology (2019) ncbi
domestic rabbit 单克隆(C84E11)
  • 免疫印迹; 小鼠; 1:1000; 图 4c
赛信通(上海)生物试剂有限公司 IKKbeta抗体(Cell signaling technology, 2078)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 4c). Nat Commun (2018) ncbi
domestic rabbit 单克隆(C84E11)
  • 免疫印迹; 小鼠; 1:1000; 图 3g
赛信通(上海)生物试剂有限公司 IKKbeta抗体(Cell Signaling, 2078)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 3g). Biochem Biophys Res Commun (2018) ncbi
domestic rabbit 单克隆(D30C6)
  • 免疫印迹; 人类; 1:1000; 图 4f
赛信通(上海)生物试剂有限公司 IKKbeta抗体(Cell Signaling, 8943)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 4f). Nature (2018) ncbi
domestic rabbit 多克隆
  • 免疫沉淀; 人类; 图 3e
赛信通(上海)生物试剂有限公司 IKKbeta抗体(Cell Signaling Technology., 2678)被用于被用于免疫沉淀在人类样本上 (图 3e). Sci Adv (2018) ncbi
domestic rabbit 单克隆(D30C6)
  • 免疫印迹; 大鼠; 图 2a
赛信通(上海)生物试剂有限公司 IKKbeta抗体(BD Biosciences, 8943)被用于被用于免疫印迹在大鼠样本上 (图 2a). Front Mol Neurosci (2018) ncbi
domestic rabbit 单克隆(D30C6)
  • 免疫印迹基因敲除验证; 人类; 图 3
赛信通(上海)生物试剂有限公司 IKKbeta抗体(Cell Signaling, 8943)被用于被用于免疫印迹基因敲除验证在人类样本上 (图 3). Cell Death Dis (2018) ncbi
domestic rabbit 单克隆(C84E11)
  • 免疫印迹; 小鼠; 图 6c
赛信通(上海)生物试剂有限公司 IKKbeta抗体(Cell Signaling, 2078)被用于被用于免疫印迹在小鼠样本上 (图 6c). Cell (2018) ncbi
domestic rabbit 多克隆
赛信通(上海)生物试剂有限公司 IKKbeta抗体(Cell Signaling, 2678)被用于. JCI Insight (2018) ncbi
domestic rabbit 单克隆(2C8)
  • 免疫印迹基因敲除验证; 人类; 图 7e
赛信通(上海)生物试剂有限公司 IKKbeta抗体(Cell Signaling, 2370)被用于被用于免疫印迹基因敲除验证在人类样本上 (图 7e). PLoS Pathog (2017) ncbi
domestic rabbit 单克隆(C84E11)
  • 免疫印迹; 人类; 图 1b
赛信通(上海)生物试剂有限公司 IKKbeta抗体(Cell Signaling, 2078)被用于被用于免疫印迹在人类样本上 (图 1b). PLoS Pathog (2017) ncbi
domestic rabbit 单克隆(2C8)
  • 免疫印迹; 人类; 1:1000; 图 2c
赛信通(上海)生物试剂有限公司 IKKbeta抗体(Cell Signaling, 2370)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 2c). Am J Physiol Heart Circ Physiol (2018) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 3a
赛信通(上海)生物试剂有限公司 IKKbeta抗体(Cell Signaling, 2684)被用于被用于免疫印迹在人类样本上 (图 3a). J Virol (2017) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 2b
赛信通(上海)生物试剂有限公司 IKKbeta抗体(Cell Signaling Technology, 2684)被用于被用于免疫印迹在人类样本上 (图 2b). Oncotarget (2017) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 1b
赛信通(上海)生物试剂有限公司 IKKbeta抗体(cell signalling, 2678)被用于被用于免疫印迹在人类样本上 (图 1b). Cell Death Dis (2017) ncbi
domestic rabbit 单克隆(2C8)
  • 免疫印迹; 小鼠; 图 5b
赛信通(上海)生物试剂有限公司 IKKbeta抗体(Cell Signaling, 2370)被用于被用于免疫印迹在小鼠样本上 (图 5b). Sci Rep (2017) ncbi
domestic rabbit 单克隆(2C8)
  • 免疫印迹; 人类; 图 4b
赛信通(上海)生物试剂有限公司 IKKbeta抗体(Cell Signaling, 2370)被用于被用于免疫印迹在人类样本上 (图 4b). Oncotarget (2017) ncbi
domestic rabbit 单克隆(D30C6)
  • 免疫印迹; 小鼠; 图 6d
赛信通(上海)生物试剂有限公司 IKKbeta抗体(CST, 8943)被用于被用于免疫印迹在小鼠样本上 (图 6d). J Am Heart Assoc (2016) ncbi
domestic rabbit 单克隆(D30C6)
  • 免疫印迹; 小鼠; 图 4G
赛信通(上海)生物试剂有限公司 IKKbeta抗体(Cell signaling, D30C6)被用于被用于免疫印迹在小鼠样本上 (图 4G). J Clin Invest (2016) ncbi
domestic rabbit 单克隆(D30C6)
  • 免疫印迹; 小鼠; 1:2000; 图 9a
赛信通(上海)生物试剂有限公司 IKKbeta抗体(Cell Signaling Technology, D30C6)被用于被用于免疫印迹在小鼠样本上浓度为1:2000 (图 9a). Drug Des Devel Ther (2016) ncbi
domestic rabbit 单克隆(2C8)
  • 免疫印迹; 人类; 图 2a
赛信通(上海)生物试剂有限公司 IKKbeta抗体(Cell Signaling, CST-2370)被用于被用于免疫印迹在人类样本上 (图 2a). Oncotarget (2016) ncbi
domestic rabbit 单克隆(C84E11)
  • 免疫印迹; 小鼠; 图 3c
赛信通(上海)生物试剂有限公司 IKKbeta抗体(Cell Signaling, 2078)被用于被用于免疫印迹在小鼠样本上 (图 3c). Oncotarget (2016) ncbi
domestic rabbit 单克隆(C84E11)
  • 免疫印迹; 小鼠; 图 5a
赛信通(上海)生物试剂有限公司 IKKbeta抗体(Cell Signalling, 2078)被用于被用于免疫印迹在小鼠样本上 (图 5a). Circ Res (2016) ncbi
domestic rabbit 单克隆(2C8)
  • 免疫印迹; 人类; 图 3b
赛信通(上海)生物试剂有限公司 IKKbeta抗体(cell signalling, 2370)被用于被用于免疫印迹在人类样本上 (图 3b). Nucleic Acids Res (2016) ncbi
domestic rabbit 单克隆(C84E11)
  • 免疫印迹; 小鼠; 图 4a
赛信通(上海)生物试剂有限公司 IKKbeta抗体(Cell signaling, 2078)被用于被用于免疫印迹在小鼠样本上 (图 4a). elife (2016) ncbi
domestic rabbit 单克隆(C84E11)
  • 免疫印迹; 人类; 图 4
赛信通(上海)生物试剂有限公司 IKKbeta抗体(Cell signaling, 2078P)被用于被用于免疫印迹在人类样本上 (图 4). Nat Immunol (2016) ncbi
domestic rabbit 单克隆(2C8)
  • 免疫印迹; 小鼠; 1:1000; 图 6
赛信通(上海)生物试剂有限公司 IKKbeta抗体(Cell Signaling, 2370)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 6). Nat Commun (2016) ncbi
domestic rabbit 单克隆(2C8)
  • 免疫印迹; 人类; 图 5d
赛信通(上海)生物试剂有限公司 IKKbeta抗体(Cell signaling, 2370)被用于被用于免疫印迹在人类样本上 (图 5d). J Exp Med (2015) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类; 图 4
赛信通(上海)生物试剂有限公司 IKKbeta抗体(Cell signaling, 2684)被用于被用于免疫印迹在人类样本上 (图 4). Cell Mol Life Sci (2016) ncbi
domestic rabbit 单克隆(C84E11)
  • 免疫印迹; 小鼠; 图 1
  • 免疫印迹; 人类; 图 s1
赛信通(上海)生物试剂有限公司 IKKbeta抗体(Cell Signaling, 2078)被用于被用于免疫印迹在小鼠样本上 (图 1) 和 被用于免疫印迹在人类样本上 (图 s1). Sci Rep (2015) ncbi
domestic rabbit 单克隆(D30C6)
  • 免疫沉淀; 小鼠; 图 3a
赛信通(上海)生物试剂有限公司 IKKbeta抗体(Cell Signaling Technology, 8943)被用于被用于免疫沉淀在小鼠样本上 (图 3a). Cell Signal (2015) ncbi
domestic rabbit 单克隆(C84E11)
  • 免疫印迹; 人类; 图 f4
赛信通(上海)生物试剂有限公司 IKKbeta抗体(cell signaling technology, 2078S)被用于被用于免疫印迹在人类样本上 (图 f4). Oncotarget (2015) ncbi
domestic rabbit 单克隆(2C8)
  • 免疫印迹; 人类; 图 1
赛信通(上海)生物试剂有限公司 IKKbeta抗体(Cell Signaling, 2370)被用于被用于免疫印迹在人类样本上 (图 1). Oncogene (2015) ncbi
domestic rabbit 单克隆(C84E11)
  • 免疫印迹; 人类; 图 2
赛信通(上海)生物试剂有限公司 IKKbeta抗体(Cell Signaling Technology, 2078)被用于被用于免疫印迹在人类样本上 (图 2). Nucleic Acids Res (2015) ncbi
domestic rabbit 单克隆(2C8)
  • 免疫印迹; 人类; 图 s2a
赛信通(上海)生物试剂有限公司 IKKbeta抗体(Cell Signaling Technology, 2370)被用于被用于免疫印迹在人类样本上 (图 s2a). Nucleic Acids Res (2015) ncbi
domestic rabbit 单克隆(D30C6)
  • 免疫印迹; 人类; 图 2
赛信通(上海)生物试剂有限公司 IKKbeta抗体(Cell Signaling, 8943)被用于被用于免疫印迹在人类样本上 (图 2). Sci Rep (2015) ncbi
domestic rabbit 单克隆(C84E11)
  • 免疫印迹; 小鼠; 图 6
赛信通(上海)生物试剂有限公司 IKKbeta抗体(Cell signaling, 2078)被用于被用于免疫印迹在小鼠样本上 (图 6). Infect Immun (2015) ncbi
domestic rabbit 单克隆(C84E11)
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司 IKKbeta抗体(Cell Signaling Technology, 2078)被用于被用于免疫印迹在人类样本上. J Invest Dermatol (2015) ncbi
domestic rabbit 单克隆(D30C6)
  • 免疫印迹; 小鼠; 图 6
赛信通(上海)生物试剂有限公司 IKKbeta抗体(Cell signaling, 8943)被用于被用于免疫印迹在小鼠样本上 (图 6). Nat Commun (2014) ncbi
domestic rabbit 单克隆(C84E11)
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司 IKKbeta抗体(Cell Signaling Technology, 2078)被用于被用于免疫印迹在人类样本上. Cell Death Dis (2014) ncbi
domestic rabbit 单克隆(C84E11)
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司 IKKbeta抗体(Cell Signaling Technology, C84E11)被用于被用于免疫印迹在人类样本上. J Virol (2013) ncbi
domestic rabbit 单克隆(C84E11)
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司 IKKbeta抗体(Cell Signaling, C84E11)被用于被用于免疫印迹在人类样本上. J Biol Chem (2012) ncbi
domestic rabbit 单克隆(2C8)
  • 免疫印迹基因敲除验证; 小鼠; 1 ug/ml; 图 1
赛信通(上海)生物试剂有限公司 IKKbeta抗体(Cell Signaling, 2C8)被用于被用于免疫印迹基因敲除验证在小鼠样本上浓度为1 ug/ml (图 1). Nat Immunol (2007) ncbi
Bioworld
domestic rabbit 多克隆
  • 免疫印迹; 小鼠; 图 2
Bioworld IKKbeta抗体(Bioworld Technology, BS1407)被用于被用于免疫印迹在小鼠样本上 (图 2). Cell Signal (2016) ncbi
domestic rabbit 多克隆
  • 免疫印迹; 人类
Bioworld IKKbeta抗体(Bioworld Technology, BS1407)被用于被用于免疫印迹在人类样本上. J Diabetes (2016) ncbi
文章列表
  1. Zhu Y, Gu H, Yang L, Li N, Chen Q, Kang D, et al. Involvement of MST1/mTORC1/STAT1 activity in the regulation of B-cell receptor signalling by chemokine receptor 2. Clin Transl Med. 2022;12:e887 pubmed 出版商
  2. Ma S, Xu H, Huang W, Gao Y, Zhou H, Li X, et al. Chrysophanol Relieves Cisplatin-Induced Nephrotoxicity via Concomitant Inhibition of Oxidative Stress, Apoptosis, and Inflammation. Front Physiol. 2021;12:706359 pubmed 出版商
  3. Wang X, Yung M, Sharma R, Chen F, Poon Y, Lam W, et al. Epigenetic Silencing of miR-33b Promotes Peritoneal Metastases of Ovarian Cancer by Modulating the TAK1/FASN/CPT1A/NF-κB Axis. Cancers (Basel). 2021;13: pubmed 出版商
  4. Qiu L, Chen M, Wang X, Chen S, Ying Z. PM2.5 Exposure of Mice during Spermatogenesis: A Role of Inhibitor κB Kinase 2 in Pro-Opiomelanocortin Neurons. Environ Health Perspect. 2021;129:97006 pubmed 出版商
  5. Xu X, Sun Y, Cen X, Shan B, Zhao Q, Xie T, et al. Metformin activates chaperone-mediated autophagy and improves disease pathologies in an Alzheimer disease mouse model. Protein Cell. 2021;: pubmed 出版商
  6. Chen S, Liu H, Li Z, Tang J, Huang B, Zhi F, et al. Epithelial PBLD attenuates intestinal inflammatory response and improves intestinal barrier function by inhibiting NF-κB signaling. Cell Death Dis. 2021;12:563 pubmed 出版商
  7. Zong X, Xiao X, Shen B, Jiang Q, Wang H, Lu Z, et al. The N6-methyladenosine RNA-binding protein YTHDF1 modulates the translation of TRAF6 to mediate the intestinal immune response. Nucleic Acids Res. 2021;49:5537-5552 pubmed 出版商
  8. Zhang G, Li R, Li W, Yang S, Sun Q, Yin H, et al. Toll-like receptor 3 ablation prevented high-fat diet-induced obesity and metabolic disorder. J Nutr Biochem. 2021;95:108761 pubmed 出版商
  9. Watahiki A, Hoshikawa S, Chiba M, Egusa H, Fukumoto S, Inuzuka H. Deficiency of Lipin2 Results in Enhanced NF-κB Signaling and Osteoclast Formation in RAW-D Murine Macrophages. Int J Mol Sci. 2021;22: pubmed 出版商
  10. Fang Y, Jiang Q, Li S, Zhu H, Xu R, Song N, et al. Opposing functions of β-arrestin 1 and 2 in Parkinson's disease via microglia inflammation and Nprl3. Cell Death Differ. 2021;28:1822-1836 pubmed 出版商
  11. Zhang R, Guo N, Yan G, Wang Q, Gao T, Zhang B, et al. Ginkgolide C attenuates lipopolysaccharide‑induced acute lung injury by inhibiting inflammation via regulating the CD40/NF‑κB signaling pathway. Int J Mol Med. 2021;47: pubmed 出版商
  12. Yu Z, Li X, Yang M, Huang J, Fang Q, Jia J, et al. TRIM41 is required to innate antiviral response by polyubiquitinating BCL10 and recruiting NEMO. Signal Transduct Target Ther. 2021;6:90 pubmed 出版商
  13. Moser B, Hochreiter B, Basílio J, Gleitsmann V, Panhuber A, Pardo Garcia A, et al. The inflammatory kinase IKKα phosphorylates and stabilizes c-Myc and enhances its activity. Mol Cancer. 2021;20:16 pubmed 出版商
  14. Wang Z, Shi Y, Ying C, Jiang Y, Hu J. Hypoxia-induced PLOD1 overexpression contributes to the malignant phenotype of glioblastoma via NF-κB signaling. Oncogene. 2021;: pubmed 出版商
  15. Li X, Zhang M, Huang X, Liang W, Li G, Lu X, et al. Ubiquitination of RIPK1 regulates its activation mediated by TNFR1 and TLRs signaling in distinct manners. Nat Commun. 2020;11:6364 pubmed 出版商
  16. Li J, Zhang L, Zheng Y, Shao R, Liang Q, Yu W, et al. BAD inactivation exacerbates rheumatoid arthritis pathology by promoting survival of sublining macrophages. elife. 2020;9: pubmed 出版商
  17. Wu Y, Chou T, Young L, Hsieh F, Pan H, Mo S, et al. Tumor suppressor death-associated protein kinase 1 inhibits necroptosis by p38 MAPK activation. Cell Death Dis. 2020;11:305 pubmed 出版商
  18. von Roemeling C, Wang Y, Qie Y, Yuan H, Zhao H, Liu X, et al. Therapeutic modulation of phagocytosis in glioblastoma can activate both innate and adaptive antitumour immunity. Nat Commun. 2020;11:1508 pubmed 出版商
  19. Zhang Y, Mao X, Chen W, Guo X, Yu L, Jiang F, et al. A Discovery of Clinically Approved Formula FBRP for Repositioning to Treat HCC by Inhibiting PI3K/AKT/NF-κB Activation. Mol Ther Nucleic Acids. 2020;19:890-904 pubmed 出版商
  20. Wang H, Chen Z, Wang S, Gao X, Qian M, Qiu W, et al. TGFβ1-induced beta-site APP-cleaving enzyme 2 upregulation promotes tumorigenesis through the NF-κB signalling pathway in human gliomas. Mol Oncol. 2020;14:407-425 pubmed 出版商
  21. Tasdogan A, Faubert B, Ramesh V, Ubellacker J, Shen B, Solmonson A, et al. Metabolic heterogeneity confers differences in melanoma metastatic potential. Nature. 2020;577:115-120 pubmed 出版商
  22. Huang X, Ni B, Xi Y, Chu X, Zhang R, You H. Protease-activated receptor 2 (PAR-2) antagonist AZ3451 as a novel therapeutic agent for osteoarthritis. Aging (Albany NY). 2019;11:12532-12545 pubmed 出版商
  23. Abe H, Satoh J, Shirasaka Y, Kogure A, Kato H, Ito S, et al. Priming Phosphorylation of TANK-Binding Kinase 1 by IκB Kinase β Is Essential in Toll-Like Receptor 3/4 Signaling. Mol Cell Biol. 2020;40: pubmed 出版商
  24. Wang Q, Yang Q, Zhang A, Kang Z, Wang Y, Zhang Z. Silencing of SPARC represses heterotopic ossification via inhibition of the MAPK signaling pathway. Biosci Rep. 2019;39: pubmed 出版商
  25. Xu G, Xia Z, Deng F, Liu L, Wang Q, Yu Y, et al. Inducible LGALS3BP/90K activates antiviral innate immune responses by targeting TRAF6 and TRAF3 complex. PLoS Pathog. 2019;15:e1008002 pubmed 出版商
  26. Zhang R, Liu Y, Chen Y, Li Q, Marshall C, Wu T, et al. Aquaporin 4 deletion exacerbates brain impairments in a mouse model of chronic sleep disruption. CNS Neurosci Ther. 2020;26:228-239 pubmed 出版商
  27. Colomer C, Margalef P, Villanueva A, Vert A, Pecharroman I, Sole L, et al. IKKα Kinase Regulates the DNA Damage Response and Drives Chemo-resistance in Cancer. Mol Cell. 2019;75:669-682.e5 pubmed 出版商
  28. Gu C, Wang L, Zurawski S, Oh S. Signaling Cascade through DC-ASGPR Induces Transcriptionally Active CREB for IL-10 Induction and Immune Regulation. J Immunol. 2019;: pubmed 出版商
  29. Yang S, Harding A, Sweeney C, Miao D, Swan G, Zhou C, et al. Control of antiviral innate immune response by protein geranylgeranylation. Sci Adv. 2019;5:eaav7999 pubmed 出版商
  30. Ye P, Liu J, Xu W, Liu D, Ding X, Le S, et al. Dual-Specificity Phosphatase 26 Protects Against Nonalcoholic Fatty Liver Disease in Mice Through Transforming Growth Factor Beta-Activated Kinase 1 Suppression. Hepatology. 2019;69:1946-1964 pubmed 出版商
  31. Panda S, Gekara N. The deubiquitinase MYSM1 dampens NOD2-mediated inflammation and tissue damage by inactivating the RIP2 complex. Nat Commun. 2018;9:4654 pubmed 出版商
  32. Zhang X, Zhang M, Wang C. Loss of LRRC25 accelerates pathological cardiac hypertrophy through promoting fibrosis and inflammation regulated by TGF-β1. Biochem Biophys Res Commun. 2018;506:137-144 pubmed 出版商
  33. Deng M, Gui X, Kim J, Xie L, Chen W, Li Z, et al. LILRB4 signalling in leukaemia cells mediates T cell suppression and tumour infiltration. Nature. 2018;562:605-609 pubmed 出版商
  34. Chuang H, Tsai C, Hsueh C, Tan T. GLK-IKKβ signaling induces dimerization and translocation of the AhR-RORγt complex in IL-17A induction and autoimmune disease. Sci Adv. 2018;4:eaat5401 pubmed 出版商
  35. Liu L, An D, Xu J, Shao B, Li X, Shi J. Ac2-26 Induces IKKβ Degradation Through Chaperone-Mediated Autophagy Via HSPB1 in NCM-Treated Microglia. Front Mol Neurosci. 2018;11:76 pubmed 出版商
  36. Makhov P, Naito S, Haifler M, Kutikov A, Boumber Y, Uzzo R, et al. The convergent roles of NF-κB and ER stress in sunitinib-mediated expression of pro-tumorigenic cytokines and refractory phenotype in renal cell carcinoma. Cell Death Dis. 2018;9:374 pubmed 出版商
  37. Zhao P, Wong K, Sun X, Reilly S, Uhm M, Liao Z, et al. TBK1 at the Crossroads of Inflammation and Energy Homeostasis in Adipose Tissue. Cell. 2018;172:731-743.e12 pubmed 出版商
  38. Sui Y, Liu Z, Park S, Thatcher S, Zhu B, Fernandez J, et al. IKKβ is a β-catenin kinase that regulates mesenchymal stem cell differentiation. JCI Insight. 2018;3: pubmed 出版商
  39. Fang R, Jiang Q, Zhou X, Wang C, Guan Y, Tao J, et al. MAVS activates TBK1 and IKK? through TRAFs in NEMO dependent and independent manner. PLoS Pathog. 2017;13:e1006720 pubmed 出版商
  40. Padilla J, Carpenter A, Das N, Kandikattu H, López Ongil S, Martinez Lemus L, et al. TRAF3IP2 mediates high glucose-induced endothelin-1 production as well as endothelin-1-induced inflammation in endothelial cells. Am J Physiol Heart Circ Physiol. 2018;314:H52-H64 pubmed 出版商
  41. Lv R, Zhao J, Lei M, Xiao D, Yu Y, Xie J. IL-33 Attenuates Sepsis by Inhibiting IL-17 Receptor Signaling through Upregulation of SOCS3. Cell Physiol Biochem. 2017;42:1961-1972 pubmed 出版商
  42. Franz S, Rennert P, Woznik M, Grützke J, Lüdde A, Arriero Pais E, et al. Mumps Virus SH Protein Inhibits NF-κB Activation by Interacting with Tumor Necrosis Factor Receptor 1, Interleukin-1 Receptor 1, and Toll-Like Receptor 3 Complexes. J Virol. 2017;91: pubmed 出版商
  43. Wang X, Wang R, Luo M, Li C, Wang H, Huan C, et al. (DEAD)-box RNA helicase 3 modulates NF-κB signal pathway by controlling the phosphorylation of PP2A-C subunit. Oncotarget. 2017;8:33197-33213 pubmed 出版商
  44. Sahu U, Choudhury A, Parvez S, Biswas S, Kar S. Induction of intestinal stemness and tumorigenicity by aberrant internalization of commensal non-pathogenic E. coli. Cell Death Dis. 2017;8:e2667 pubmed 出版商
  45. Gatla H, Zou Y, Uddin M, Singha B, Bu P, Vancura A, et al. Histone Deacetylase (HDAC) Inhibition Induces IκB Kinase (IKK)-dependent Interleukin-8/CXCL8 Expression in Ovarian Cancer Cells. J Biol Chem. 2017;292:5043-5054 pubmed 出版商
  46. Zhang H, Qi Y, Yuan Y, Cai L, Xu H, Zhang L, et al. Paeoniflorin Ameliorates Experimental Autoimmune Encephalomyelitis via Inhibition of Dendritic Cell Function and Th17 Cell Differentiation. Sci Rep. 2017;7:41887 pubmed 出版商
  47. Mondello P, Derenzini E, Asgari Z, Philip J, Brea E, SESHAN V, et al. Dual inhibition of histone deacetylases and phosphoinositide 3-kinase enhances therapeutic activity against B cell lymphoma. Oncotarget. 2017;8:14017-14028 pubmed 出版商
  48. Chao M, Guo J, Cheng W, Zhu X, She Z, Huang Z, et al. Loss of Caspase-Activated DNase Protects Against Atherosclerosis in Apolipoprotein E-Deficient Mice. J Am Heart Assoc. 2016;5: pubmed 出版商
  49. Lin C, Lin W, Cho R, Wang C, Hsiao L, Yang C. TNF-?-Induced cPLA2 Expression via NADPH Oxidase/Reactive Oxygen Species-Dependent NF-?B Cascade on Human Pulmonary Alveolar Epithelial Cells. Front Pharmacol. 2016;7:447 pubmed
  50. Marichal T, Gaudenzio N, El Abbas S, Sibilano R, Zurek O, Starkl P, et al. Guanine nucleotide exchange factor RABGEF1 regulates keratinocyte-intrinsic signaling to maintain skin homeostasis. J Clin Invest. 2016;126:4497-4515 pubmed 出版商
  51. He Y, Yan Y, Zhang H, Lin Y, Chen Y, Yan Y, et al. Methyl salicylate 2-O-?-d-lactoside alleviates the pathological progression of pristane-induced systemic lupus erythematosus-like disease in mice via suppression of inflammatory response and signal transduction. Drug Des Devel Ther. 2016;10:3183-3196 pubmed
  52. Scholefield J, Henriques R, Savulescu A, Fontan E, Boucharlat A, Laplantine E, et al. Super-resolution microscopy reveals a preformed NEMO lattice structure that is collapsed in incontinentia pigmenti. Nat Commun. 2016;7:12629 pubmed 出版商
  53. Reid M, Lowman X, Pan M, Tran T, Warmoes M, Ishak Gabra M, et al. IKKβ promotes metabolic adaptation to glutamine deprivation via phosphorylation and inhibition of PFKFB3. Genes Dev. 2016;30:1837-51 pubmed 出版商
  54. Oh B, Kim S, Lee Y, Hong H, Kim T, Kim S, et al. Twist1-induced epithelial-mesenchymal transition according to microsatellite instability status in colon cancer cells. Oncotarget. 2016;7:57066-57076 pubmed 出版商
  55. Zhou Y, Xu H, Ding Y, Lu Q, Zou M, Song P. AMPK?1 deletion in fibroblasts promotes tumorigenesis in athymic nude mice by p52-mediated elevation of erythropoietin and CDK2. Oncotarget. 2016;7:53654-53667 pubmed 出版商
  56. Cameron A, Morrison V, Levin D, Mohan M, Forteath C, Beall C, et al. Anti-Inflammatory Effects of Metformin Irrespective of Diabetes Status. Circ Res. 2016;119:652-65 pubmed 出版商
  57. Taminiau A, Draime A, Tys J, Lambert B, Vandeputte J, Nguyen N, et al. HOXA1 binds RBCK1/HOIL-1 and TRAF2 and modulates the TNF/NF-?B pathway in a transcription-independent manner. Nucleic Acids Res. 2016;44:7331-49 pubmed 出版商
  58. Ni T, Liu Y, Peng Y, Li M, Fang Y, Yao M. Substance P induces inflammatory responses involving NF-?B in genetically diabetic mice skin fibroblasts co-cultured with macrophages. Am J Transl Res. 2016;8:2179-88 pubmed
  59. Zhao W, Li A, Feng X, Hou T, Liu K, Liu B, et al. Metformin and resveratrol ameliorate muscle insulin resistance through preventing lipolysis and inflammation in hypoxic adipose tissue. Cell Signal. 2016;28:1401-11 pubmed 出版商
  60. Yu Z, Chen T, Li X, Yang M, Tang S, Zhu X, et al. Lys29-linkage of ASK1 by Skp1-Cullin 1-Fbxo21 ubiquitin ligase complex is required for antiviral innate response. elife. 2016;5: pubmed 出版商
  61. Starokadomskyy P, Gemelli T, Rios J, Xing C, Wang R, Li H, et al. DNA polymerase-? regulates the activation of type I interferons through cytosolic RNA:DNA synthesis. Nat Immunol. 2016;17:495-504 pubmed 出版商
  62. Ranjan K, Pathak C. FADD regulates NF-κB activation and promotes ubiquitination of cFLIPL to induce apoptosis. Sci Rep. 2016;6:22787 pubmed 出版商
  63. Wang P, Zhang X, Luo P, Jiang X, Zhang P, Guo J, et al. Hepatocyte TRAF3 promotes liver steatosis and systemic insulin resistance through targeting TAK1-dependent signalling. Nat Commun. 2016;7:10592 pubmed 出版商
  64. Yamagishi M, Katano H, Hishima T, Shimoyama T, Ota Y, Nakano K, et al. Coordinated loss of microRNA group causes defenseless signaling in malignant lymphoma. Sci Rep. 2015;5:17868 pubmed 出版商
  65. Kraut B, Maier H, Kókai E, Fiedler K, Boettger T, Illing A, et al. Cardiac-Specific Activation of IKK2 Leads to Defects in Heart Development and Embryonic Lethality. PLoS ONE. 2015;10:e0141591 pubmed 出版商
  66. Varney M, Niederkorn M, Konno H, Matsumura T, Gohda J, Yoshida N, et al. Loss of Tifab, a del(5q) MDS gene, alters hematopoiesis through derepression of Toll-like receptor-TRAF6 signaling. J Exp Med. 2015;212:1967-85 pubmed 出版商
  67. Suzuki M, Watanabe M, Nakamaru Y, Takagi D, Takahashi H, Fukuda S, et al. TRIM39 negatively regulates the NFκB-mediated signaling pathway through stabilization of Cactin. Cell Mol Life Sci. 2016;73:1085-101 pubmed 出版商
  68. Fan H, Yang M, Qi D, Zhang Z, Zhu L, Shang Guan X, et al. Salvianolic acid A as a multifunctional agent ameliorates doxorubicin-induced nephropathy in rats. Sci Rep. 2015;5:12273 pubmed 出版商
  69. Chen I, Hsu P, Hsu W, Chen N, Tseng P. Polyubiquitination of Transforming Growth Factor β-activated Kinase 1 (TAK1) at Lysine 562 Residue Regulates TLR4-mediated JNK and p38 MAPK Activation. Sci Rep. 2015;5:12300 pubmed 出版商
  70. Somanna N, Yariswamy M, Garagliano J, Siebenlist U, Mummidi S, Valente A, et al. Aldosterone-induced cardiomyocyte growth, and fibroblast migration and proliferation are mediated by TRAF3IP2. Cell Signal. 2015;27:1928-38 pubmed 出版商
  71. Romano S, Xiao Y, Nakaya M, D Angelillo A, Chang M, Jin J, et al. FKBP51 employs both scaffold and isomerase functions to promote NF-κB activation in melanoma. Nucleic Acids Res. 2015;43:6983-93 pubmed 出版商
  72. Kiebala M, Singh M, Piepenbrink M, Qiu X, Kobie J, Maggirwar S. Platelet Activation in Human Immunodeficiency Virus Type-1 Patients Is Not Altered with Cocaine Abuse. PLoS ONE. 2015;10:e0130061 pubmed 出版商
  73. Chen P, Wu T, Cheng Y, Chen C, Lee H. NKX2-1-mediated p53 expression modulates lung adenocarcinoma progression via modulating IKKβ/NF-κB activation. Oncotarget. 2015;6:14274-89 pubmed
  74. Yang L, Zhang S, George S, Teng R, You X, Xu M, et al. Targeting Notch1 and proteasome as an effective strategy to suppress T-cell lymphoproliferative neoplasms. Oncotarget. 2015;6:14953-69 pubmed
  75. Liu Z, Jiang C, Zhang J, Liu B, Du Q. Resveratrol inhibits inflammation and ameliorates insulin resistant endothelial dysfunction via regulation of AMP-activated protein kinase and sirtuin 1 activities. J Diabetes. 2016;8:324-35 pubmed 出版商
  76. Strohecker A, Joshi S, Possemato R, Abraham R, Sabatini D, White E. Identification of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase as a novel autophagy regulator by high content shRNA screening. Oncogene. 2015;34:5662-76 pubmed 出版商
  77. Wu Z, Wang C, Bai M, Li X, Mei Q, Li X, et al. An LRP16-containing preassembly complex contributes to NF-κB activation induced by DNA double-strand breaks. Nucleic Acids Res. 2015;43:3167-79 pubmed 出版商
  78. Kobayashi K, Sakurai K, Hiramatsu H, Inada K, Shiogama K, Nakamura S, et al. The miR-199a/Brm/EGR1 axis is a determinant of anchorage-independent growth in epithelial tumor cell lines. Sci Rep. 2015;5:8428 pubmed 出版商
  79. Kim K, Kim N, Kim S, Kim I, Kim K, Lee G. Cyclo(Phe-Pro) produced by the human pathogen Vibrio vulnificus inhibits host innate immune responses through the NF-κB pathway. Infect Immun. 2015;83:1150-61 pubmed 出版商
  80. Wu N, Huang D, Tsou H, Lin Y, Lin W. Syk mediates IL-17-induced CCL20 expression by targeting Act1-dependent K63-linked ubiquitination of TRAF6. J Invest Dermatol. 2015;135:490-498 pubmed 出版商
  81. Tang S, Chen T, Yu Z, Zhu X, Yang M, Xie B, et al. RasGRP3 limits Toll-like receptor-triggered inflammatory response in macrophages by activating Rap1 small GTPase. Nat Commun. 2014;5:4657 pubmed 出版商
  82. Cheng J, Fan Y, Xu X, Dou J, Tang Y, Zhong X, et al. A small-molecule inhibitor of UBE2N induces neuroblastoma cell death via activation of p53 and JNK pathways. Cell Death Dis. 2014;5:e1079 pubmed 出版商
  83. Liu Y, Hawkins O, Su Y, Vilgelm A, Sobolik T, Thu Y, et al. Targeting aurora kinases limits tumour growth through DNA damage-mediated senescence and blockade of NF-?B impairs this drug-induced senescence. EMBO Mol Med. 2013;5:149-66 pubmed 出版商
  84. Journo C, Bonnet A, Favre Bonvin A, Turpin J, Vinera J, C t E, et al. Human T cell leukemia virus type 2 tax-mediated NF-?B activation involves a mechanism independent of Tax conjugation to ubiquitin and SUMO. J Virol. 2013;87:1123-36 pubmed 出版商
  85. Lecat A, Di Valentin E, Somja J, Jourdan S, Fillet M, Kufer T, et al. The c-Jun N-terminal kinase (JNK)-binding protein (JNKBP1) acts as a negative regulator of NOD2 protein signaling by inhibiting its oligomerization process. J Biol Chem. 2012;287:29213-26 pubmed 出版商
  86. Zhao T, Yang L, Sun Q, Arguello M, Ballard D, Hiscott J, et al. The NEMO adaptor bridges the nuclear factor-kappaB and interferon regulatory factor signaling pathways. Nat Immunol. 2007;8:592-600 pubmed